<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Why DexCom (DXCM) Shares Are Sliding Today — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Why DexCom (DXCM) Shares Are Sliding Today</h2>
    <div class="badge">2025-09-08T15:45:57+00:00</div>
    <ul>
      <li>DexCom is up 0.8% since the beginning of the year, but at $79.17 per share, it is still trading 12.8% below its 52-week high of $90.75 from February 2025.</li>
<li>In addition to the downgrade, Oppenheimer also removed its $102 price target for the medical device maker.</li>
<li>What Is The Market Telling Us DexCom’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year.</li>
<li>The previous big move we wrote about was 4 days ago when the stock gained 3.3% on the news that company executives provided an optimistic outlook at the Wells Fargo Healthcare Conference.</li>
<li>Investors who bought $1,000 worth of DexCom’s shares 5 years ago would now be looking at an investment worth $813.64.</li>
<li>Shares of medical device company DexCom (NASDAQ:DXCM) fell 2% in the morning session after Oppenheimer downgraded the stock to Perform from a previous Outperform rating.</li>
<li>What Happened?</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Why%20DexCom%20%28DXCM%29%20Shares%20Are%20Sliding%20Today%0A%E2%80%A2%20DexCom%20is%20up%200.8%25%20since%20the%20beginning%20of%20the%20year%2C%20but%20at%20%2479.17%20per%20share%2C%20it%20is%20still%20trading%2012.8%25%20below%20its%2052-week%20high%20of%20%2490.75%20from%20February%202025.%0A%E2%80%A2%20In%20addition%20to%20the%20downgrade%2C%20Oppenheimer%20also%20removed%20its%20%24102%20price%20target%20for%20the%20medical%20device%20maker.%0A%E2%80%A2%20What%20Is%20The%20Market%20Telling%20Us%20DexCom%E2%80%99s%20shares%20are%20somewhat%20volatile%20and%20have%20had%2014%20moves%20greater%20than%205%25%20over%20the%20last%20year.%0A%E2%80%A2%20The%20previous%20big%20move%20we%20wrote%20about%20was%204%20days%20ago%20when%20the%20stock%20gained%203.3%25%20on%20the%20news%20that%20company%20executives%20provided%20an%20optimistic%20outlook%20at%20the%20Wells%20Fargo%20Healthcare%20Conference.%0A%E2%80%A2%20Investors%20who%20bought%20%241%2C000%20worth%20of%20DexCom%E2%80%99s%20shares%205%20years%20ago%20would%20now%20be%20looking%20at%20an%20investment%20worth%20%24813.64.%0A%E2%80%A2%20Shares%20of%20medical%20device%20company%20DexCom%20%28NASDAQ%3ADXCM%29%20fell%202%25%20in%20the%20morning%20session%20after%20Oppenheimer%20downgraded%20the%20stock%20to%20Perform%20from%20a%20previous%20Outperform%20rating.%0A%E2%80%A2%20What%20Happened%3F&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Fwhy-dexcom-dxcm-shares-are-sliding-today%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/why-dexcom-dxcm-shares-sliding-154557286.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>